Arbutus to Present at JMP Securities Life Sciences Conference
WARMINSTER, Pa., May 09, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop novel therapeutics that target... | May 9, 2023